Stratec Se

Stratec Se Equity Turnover

The Equity Turnover of Stratec Se (SBS.DE) as of Oct 30, 2026 is 1.06. In the previous year, Equity Turnover was 1.06 — a change of -0.49% (lower).

Equity Turnover

1.06

YoY

-0.49%

Last updated:

Equity Turnover of Stratec Se is 2025 1.06 . Equity Turnover of Stratec Se was 2024 1.06 . It decreases by -0.49% lower compared to the previous year.

The Stratec Se Equity Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Turnover
Date
Equity Turnover
Jan 1, 2018
1.23 EUR
Jan 1, 2019
1.39 EUR
Jan 1, 2020
1.45 EUR
Jan 1, 2021
1.40 EUR
Jan 1, 2022
1.22 EUR
Jan 1, 2023
1.16 EUR
Jan 1, 2024
1.06 EUR
Jan 1, 2025
1.06 EUR
The Stratec Se Equity Turnover history
YEAREquity TurnoverYoY
1.06-0.49%
1.06-8.35%
1.16-4.97%
1.22-12.67%
1.40-3.66%
1.45+3.99%
1.39+12.96%
1.23-7.15%
1.33+3.29%
1.29+14.12%
1.13-12.79%
1.29—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stratec Se Stock analysis

What does Stratec Se do? The company Stratec SE is a German company operating in the medical technology industry. It was founded in 1984 and has since become a leading provider of automation solutions and diagnostic instruments. Stratec's business model is based on the development and production of devices and systems used in medical diagnostics. The company focuses in particular on the areas of immunology, clinical chemistry, and hematology. Stratec also offers innovative solutions in microscopy and cell analysis. In the "automation solutions" division, Stratec develops systems for the automation of laboratory processes. These are mainly used in clinical diagnostics to accelerate and simplify workflow. Examples include sample identification systems, pipetting robots, and analysis devices. In the "in vitro diagnostics" division, Stratec offers products for determining blood values. This includes devices for determining glucose, cholesterol, and hemoglobin levels, as well as devices for infection diagnostics and tumor and allergy diagnostics. Another division of Stratec is "microscopy." The company manufactures automated microscope systems, primarily used in biomedical research to analyze cells and tissues. In the "cell analysis" division, Stratec offers innovative methods for analyzing cells, such as cell growth and vitality determination. Stratec always focuses on tailoring the design of its products to the needs of its customers. High flexibility in device development and manufacturing is therefore an important factor in the company's success. In addition to device development and production, Stratec also provides services related to its products. These include installation, maintenance, and on-site repair of devices for customers. Stratec SE operates internationally and has branches in Europe, Asia, and America. The company employs over 1,000 people worldwide. Overall, Stratec SE is a successful and renowned provider of medical devices and systems for automating laboratory processes. With its diverse product portfolio and high flexibility in customer support, Stratec has earned a leading position in the industry. Stratec Se is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stratec Se stock

Equity Turnover of Stratec Se is 1.06 in 2025.

Equity Turnover of Stratec Se changed from 1.06 to 1.06, representing a -0.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Turnover Stratec Se since 2006 – with annual values, charts, and detailed analysis.

Equity turnover measures how efficiently a company uses shareholders' equity to generate revenue. It is a component of the DuPont analysis framework.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Turnover's Stratec Se with sector peers and the industry average to assess whether it is attractive.

To evaluate Equity Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Equity Turnover.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Stratec Se

All Key Metrics — Stratec Se